首页> 外国专利> BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABAA RECEPTOR COMPLEX THAT ARE USEFUL IN THE TREATMENT OF VARIOUS CNS DISORDERS SUCH AS EPILEPSY AND OTHER CONVULSIVE DISORDERS

BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABAA RECEPTOR COMPLEX THAT ARE USEFUL IN THE TREATMENT OF VARIOUS CNS DISORDERS SUCH AS EPILEPSY AND OTHER CONVULSIVE DISORDERS

机译:苯并咪唑化合物及其作为GABAA受体复合物的调节剂,可用于治疗各种中枢神经系统疾病,例如癫痫和其他惊厥性疾病

摘要

PCT No. PCT/EP96/01649 Sec. 371 Date Dec. 23, 1997 Sec. 102(e) Date Dec. 23, 1997 PCT Filed Apr. 19, 1996 PCT Pub. No. WO96/33191 PCT Pub. Date Oct. 24, 1996The present patent application discloses compounds having the formula or a pharmaceutically acceptable salt thereof or an oxide thereof wherein R3 is wherein A, B and D each is CH, or one or two of A, B and D is N and the others are CH; R11 is phenyl, benzimidazolyl, or monocyclic heteroaryl, all of which may be substituted one or more times with substituents selected from alkyl, alkoxy, halogen, CF3, amino, nitro, cyano, acylamino, acyl, phenyl and monocyclic heteroaryl; one of R6 and R7 is hydrogen and the other is -CR'=NOR'', wherein R' and R'' each independently are hydrogen, alkyl, alkenyl, alkynyl or phenyl. The compounds are useful for the treartment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.
机译:PCT号PCT / EP96 / 01649秒371日期1997年12月23日秒102(e)日期,1997年12月23日PCT,1996年4月19日提交,PCT公开。 WO96 / 33191 PCT公开号日期:1996年10月24日,本专利申请公开了具有下式的化合物或其药学上可接受的盐或其氧化物,其中R 3为其中A,B和D各自为CH,或A,B和D中的一个或两个为N且其他是CH; R11是苯基,苯并咪唑基或单环杂芳基,它们都可以被选自烷基,烷氧基,卤素,CF3,氨基,硝基,氰基,酰基氨基,酰基,苯基和单环杂芳基的取代基取代一次或多次。 R6和R7之一是氢,另一个是-CR′= NOR″,其中R′和R″分别独立地是氢,烷基,烯基,炔基或苯基。该化合物可用于治疗各种中枢神经系统疾病,例如癫痫和其他惊厥性疾病,焦虑症,睡眠障碍和记忆障碍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号